Adenocarcinoma Breast Stage IV
1 clinical trials · Condition
◉ Watch Adenocarcinoma Breast Stage IV
| Record | Firm | Date |
|---|---|---|
| IMP321 (Eftilagimod Alpha) as Adjunctive to a Standard Chemotherapy Paclitaxel Metastatic Breast Carcinoma (NCT02614833) | Immutep S.A.S. | 2015-12-01 |
Track Adenocarcinoma Breast Stage IV automatically
Every clearance here is in the API, with alerts when new ones post.